• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据免疫途径的不同,抗原特异性CD8+T细胞应答的发育对CD4辅助的需求存在差异。

Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.

作者信息

Bour H, Horvath C, Lurquin C, Cerottini J C, MacDonald H R

机构信息

Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, Switzerland.

出版信息

J Immunol. 1998 Jun 1;160(11):5522-9.

PMID:9605156
Abstract

Previous studies in our laboratory have shown that DBA/2 mice injected i.p. with syngeneic P815 tumor cells transfected with the HLA-CW3 gene (P815-CW3) showed a dramatic expansion of activated CD8+CD62L- T cells expressing exclusively the Vbeta10 segment. We have used this model to study the regulatory mechanisms involved in the development of the CW3-specific CD8+ response, with respect to different routes of immunization. Whereas both intradermal (i.d.) and i.p. immunization of DBA/2 mice with P815-CW3 cells led to a strong expansion of CD8+CD62L-Vbeta10+ cells, only the i.d. route allowed this expansion after immunization with P815 cells transfected with a minigene coding for the antigenic epitope CW3 170-179 (P815 miniCW3). Furthermore, depletion of CD4+ T cells in vivo completely abolished the specific response of CD8+CD62L-Vbeta10+ cells and prevented the rejection of P815-CW3 tumor cells injected i.p., whereas it did not affect CD8S+CD62L-Vbeta10+ cell expansion after i.d. immunization with either P815-CW3 or P815 miniCW3. Finally, the CW3-specific CD8+ memory response was identical whether or not CD4+ T cells were depleted during the primary response. Collectively, these results suggest that the CD8+ T cell response to P815-CW3 tumor cells injected i.p. is strictly dependent upon recognition of a helper epitope by CD4+ T cells, whereas no such requirement is observed for i.d. injection.

摘要

我们实验室之前的研究表明,腹腔注射转染了HLA - CW3基因的同基因P815肿瘤细胞(P815 - CW3)的DBA/2小鼠,其表达唯一Vbeta10片段的活化CD8⁺CD62L⁻ T细胞显著扩增。我们利用该模型研究了关于不同免疫途径的CW3特异性CD8⁺应答发育过程中涉及的调节机制。虽然用P815 - CW3细胞对DBA/2小鼠进行皮内(i.d.)和腹腔免疫均导致CD8⁺CD62L⁻Vbeta10⁺细胞强烈扩增,但仅皮内途径在用编码抗原表位CW3 170 - 179的小基因转染的P815细胞(P815 miniCW3)免疫后允许这种扩增。此外,体内CD4⁺ T细胞的耗竭完全消除了CD8⁺CD62L⁻Vbeta10⁺细胞的特异性应答,并阻止了腹腔注射的P815 - CW3肿瘤细胞的排斥,而在用P815 - CW3或P815 miniCW3进行皮内免疫后,它并不影响CD8⁺CD62L⁻Vbeta10⁺细胞的扩增。最后,无论在初次应答期间CD4⁺ T细胞是否被耗竭,CW3特异性CD8⁺记忆应答都是相同的。总体而言,这些结果表明,对腹腔注射的P815 - CW3肿瘤细胞的CD8⁺ T细胞应答严格依赖于CD4⁺ T细胞对辅助表位的识别,而皮内注射则未观察到这种需求。

相似文献

1
Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.根据免疫途径的不同,抗原特异性CD8+T细胞应答的发育对CD4辅助的需求存在差异。
J Immunol. 1998 Jun 1;160(11):5522-9.
2
Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells.肿瘤来源的白细胞介素-4降低肿瘤清除率,并改变肿瘤诱导的CD8+ T细胞的细胞因子和颗粒酶谱。
Cancer Res. 2006 Jan 1;66(1):571-80. doi: 10.1158/0008-5472.CAN-05-1362.
3
Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.体内寡克隆CD8 + T细胞对莫洛尼白血病病毒编码的免疫显性表位反应的流式微量荧光监测。
J Immunol. 1998 Feb 15;160(4):1659-65.
4
Dramatic influence of V beta gene polymorphism on an antigen-specific CD8+ T cell response in vivo.Vβ基因多态性对体内抗原特异性CD8 + T细胞反应的显著影响。
J Immunol. 1999 Apr 15;162(8):4647-56.
5
Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides.利用重组基因和合成肽对由H-2限制的、针对HLA的细胞毒性T淋巴细胞所识别的HLA表位进行定位。
J Immunol. 1988 Feb 1;140(3):871-7.
6
Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7 X human beta 2m double transgenic mice.HLA-B7转基因小鼠与人β2微球蛋白双转基因小鼠的HLA-Cw3特异性细胞毒性T淋巴细胞反应分析。
J Immunol. 1989 Nov 15;143(10):3117-24.
7
Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.B7(CD28的天然配体)对肿瘤反应性CD4+和CD8+ T淋巴细胞的共刺激作用可用于治疗已形成的小鼠黑色素瘤。
J Immunol. 1994 Jul 1;153(1):421-8.
8
Requirement for CD4 T cell help in generating functional CD8 T cell memory.生成功能性CD8 T细胞记忆对CD4 T细胞辅助的需求。
Science. 2003 Apr 11;300(5617):337-9. doi: 10.1126/science.1082305.
9
Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.1型辅助性T细胞诱导肽增强CD8 + 细胞毒性T细胞反应及抗肿瘤抗性
Immunology. 2006 Jan;117(1):47-58. doi: 10.1111/j.1365-2567.2005.02262.x.
10
Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8+ T cell-dependent mechanism.宿主B7-1和B7-2共刺激分子通过CD8 + T细胞依赖性机制促进对转染B7-1的P815肿瘤细胞的清除。
J Immunol. 1999 Apr 15;162(8):4817-23.

引用本文的文献

1
A tumor lysate is an effective vaccine antigen for the stimulation of CD4(+) T-cell function and subsequent induction of antitumor immunity mediated by CD8(+) T cells.肿瘤裂解物是一种有效的疫苗抗原,可刺激CD4(+) T细胞功能,并随后诱导由CD8(+) T细胞介导的抗肿瘤免疫。
Cancer Biol Ther. 2015;16(11):1616-25. doi: 10.1080/15384047.2015.1078027. Epub 2015 Sep 21.
2
Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria model.脂质核心肽疫苗接种未能诱导表位特异性 T 细胞应答,但在疟疾模型中赋予非特异性保护免疫。
PLoS One. 2012;7(8):e40928. doi: 10.1371/journal.pone.0040928. Epub 2012 Aug 24.
3
Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression.
TAP1的表达可促进B7.1共刺激对基于T细胞的抗TAP阴性癌症免疫的作用。
PLoS One. 2009 Jul 24;4(7):e6385. doi: 10.1371/journal.pone.0006385.
4
In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.慢病毒疫苗的体内给药靶向树突状细胞并诱导有效的CD8(+) T细胞反应。
J Clin Invest. 2003 Jun;111(11):1673-81. doi: 10.1172/JCI17098.
5
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.gp100/pmel17和酪氨酸酶编码多个被Th1型CD4 + T细胞识别的表位。
Br J Cancer. 2001 Nov 30;85(11):1738-45. doi: 10.1054/bjoc.2001.2160.